Guardian Pharmacy Services, Inc. filings document the reporting obligations of a NYSE-listed long-term care pharmacy services company with Class A common stock. Recent Form 8-K filings furnish operating results, financial guidance, investor presentation materials, and exhibits tied to the company’s pharmacy services business.
Proxy and current-report filings also cover board elections, advisory compensation votes, stockholder voting results, material stock purchase agreements, lock-up arrangements, and conversion-related disclosures involving Class A and Class B common stock. These records describe governance, ownership, capital-structure mechanics, registered securities, and matters linked to the company’s September 2024 corporate reorganization.
Guardian Pharmacy Services, Inc. (GRDN) Senior Vice President, Chief Financial Officer William Franklin Mudd had 38,282 directly held Class B shares automatically converted into 38,282 Class A shares on September 27, 2026, on a one-for-one basis under the company's Amended and Restated Certificate of Incorporation. Afterward, his reported direct holdings were 136,747 Class A shares and 0 Class B shares.
Guardian Pharmacy Services, Inc. (GRDN) reported that its Senior Vice President, Operations & Regulatory Support, Robert Weir, had 23,450 shares of Class B common stock automatically converted into 23,450 shares of Class A common stock on September 27, 2026, on a one-for-one basis under the amended and restated certificate of incorporation. His reported direct Class A holdings after the conversion were 103,333 shares.
Guardian Pharmacy Services, Inc. director John Ackerman reported that 1,413,939 Class B shares held indirectly by Pharmacy Investors, LLC and 471,057 held by Cardinal Equity Fund, L.P. automatically converted one-for-one into Class A shares on September 27, 2026, under the company’s Amended and Restated Certificate of Incorporation.
Guardian Pharmacy Services, Inc. (GRDN) director and member of the 10% owner group Thomas J. Salentine Jr. reported that Bindley Capital Partners I, LLC automatically converted 6,100,175 Class B common shares into 6,100,175 Class A common shares on September 27, 2026, on a one-for-one basis under the company's Amended and Restated Certificate of Incorporation. After the conversion, the LLC held 16,669,666 Class A shares indirectly; Salentine also reported 35,714 Class A shares held directly.
At Guardian Pharmacy Services, Inc., Senior Vice President, Technology, Data & Senior Security Officer David Norman Martin’s 39,865 Class B common shares automatically converted into 39,865 Class A common shares on September 27, 2026, on a one-for-one basis under the company’s Amended and Restated Certificate of Incorporation.
Pharmacy Investors, LLC, identified as a member of Guardian Pharmacy Services, Inc.’s 10% owner group, reported the automatic conversion of 1,413,939 Class B common shares into 1,413,939 Class A common shares on September 27, 2026, on a one-for-one basis under the issuer’s Amended and Restated Certificate of Incorporation. Following the conversion, it reported 3,863,806 Class A shares and zero Class B shares.
Guardian Pharmacy Services, Inc. reported that President and Chief Executive Officer Fred Burke’s 1,298,825 Class B common shares automatically converted into the same number of Class A common shares on September 27, 2026, on a one-for-one basis under the company’s Amended and Restated Certificate of Incorporation. After the conversion, Burke directly held 3,438,064 Class A shares and zero Class B shares.
Guardian Pharmacy Services, Inc. (GRDN) reported that its Senior Vice President, Purchasing & Pricing Analytics, Jeffrey Tuch, had 55,578 shares of Class B common stock automatically converted into 55,578 shares of Class A common stock on September 27, 2026, on a one-for-one basis under the company’s Amended and Restated Certificate of Incorporation. After the conversion, Tuch directly held 231,847 shares of Class A common stock and 0 shares of Class B common stock.
Guardian Pharmacy Services, Inc. (symbol: GRDN) is the issuer of record for a Form 4 filing submitted to the SEC. Forbes Kendall, a member of the 10% Owner Group, had 608,570 shares of Class B common stock automatically converted one-for-one into 608,570 shares of Class A common stock on September 27, 2026. After the conversion, his reported Class A holdings were 1,651,059 shares. In connection with his retirement, he forfeited 19,337 unvested restricted stock units and 50,000 unvested stock options.
Guardian Pharmacy Services, Inc. reported that Bindley Capital Partners I, LLC’s 6,100,175 Class B common shares automatically converted into 6,100,175 Class A common shares on September 27, 2026, on a one-for-one basis under the issuer’s Amended and Restated Certificate of Incorporation. The resulting Class A position held through the LLC was 16,669,666 shares. William E. Bindley, a director and member of the 10% Owner Group, reported the position indirectly through the LLC.